Skip to content

    Viking Therapeutics (VKTX) stock price & financials

    View VKTX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+20.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $0
    $0
    $0
    $0
    $0
    $0
    Operating Profit
    -$36.56M
    -$46.24M
    -$55.47M
    -$74.57M
    -$98.56M
    -169.6%
    -$164.74M
    -256.3%
    -$164.13M
    -195.9%
    -$132.60M
    -77.8%
    Weakening
    Net Profit
    -$24.94M
    -$35.42M
    -$45.63M
    -$65.56M
    -$90.79M
    -264.0%
    -$157.66M
    -345.2%
    -$158.32M
    -247.0%
    -$128.02M
    -95.3%
    Weakening
    EPS
    $-0.22
    $-0.41
    $-0.58
    $-0.81
    -268.2%
    $-1.37
    -234.1%
    $-1.10
    -89.7%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    2.2%
    3.1%
    4.0%
    5.8%
    8.0%
    +264.0%
    13.9%
    +345.2%
    14.0%
    +247.0%
    11.3%
    +95.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$24.78M$8.38M$29.12M$26.37M$36.63M$55.52M$26.68M$165.81M$125.75M
    Short-Term Investments
    Total Current Assets$302.13M$283.50M$256.10M$210.53M$167.04M$367.23M$907.22M$715.60M$517.56M
    Net PP&E$598.0K$321.0K$25.0K$1.42M$1.13M$1.00M$85.0K$4.01M
    Goodwill
    Intangibles
    Total Assets$302.31M$284.26M$256.50M$210.66M$168.53M$368.49M$908.32M$715.73M$521.90M
    LiabilitiesTotal Current Liabilities$4.55M$6.78M$12.13M$8.78M$21.95M$19.14M$27.41M$76.67M$109.66M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$360.0K$29.0K$1.26M$936.0K$630.0K$0$3.92M
    Total Liabilities$4.56M$7.14M$12.16M$8.78M$23.21M$20.07M$28.04M$76.67M$113.58M
    EquityCommon Stock & APIC$1.0K$1.0K$1.0K$1.0K$1.0K$1.0K$1.0K$1.0K$1.0K
    Retained Earnings-$102.92M-$128.70M-$168.19M-$223.18M-$292.05M-$377.94M-$487.91M-$847.55M-$1.13B
    Total Equity$297.75M$277.12M$244.34M$201.88M$145.32M$348.42M$880.28M$639.06M$408.32M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$18.75M-$24.75M-$21.78M-$47.59M-$48.40M-$73.38M-$87.79M-$278.69M-$418.44M
    Cash from Investing-$265.73M$7.46M$41.57M$37.96M$54.75M-$179.09M-$553.37M$341.39M$399.26M
    Cash from Financing$300.27M$887.0K$950.0K$6.88M$4.16M$271.38M$612.46M$76.44M$111.25M
    SummaryCapital Expenditure
    Free Cash Flow
    FCF Margin

    Ratios